Patent ID: 9475808
Filing Date: 2016-10-25
CPC Classification: A61P,C07D

Claim Text:
1. A method for treating a medical disorder, selected from the group consisting of schizophrenia, cognitive dysfunction associated with schizophrenia, a bipolar disorder, depression, cognitive dysfunction associated with Alzheimer's disease, diet-induced obesity, Huntington's disease, and anxiety which can be treated by inhibition of phosphodiesterase type 10A, said method comprising administering an effective amount of at least one compound of formula (I) to a subject in need thereof: wherein X is CR Y is CR A is O, [C(R Het is independently selected from the group consisting of Q is O or S; Z is independently selected from the group consisting of a chemical bond, CH R R R R R R the moiety C(R the moiety C(R and where R R R R R′ is hydrogen, C an N-oxide thereof, a prodrug thereof, a tautomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof.